VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹11 Cr | ₹11 Cr | ₹-0.68 Cr | ₹3.63 Cr | ₹17 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of VENUS REMEDIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹11 Cr |
Mar2023 | ₹11 Cr |
Mar2022 | ₹-0.68 Cr |
Mar2021 | ₹3.63 Cr |
Mar2020 | ₹17 Cr |
How is Deferred Tax Assets / Liabilities of VENUS REMEDIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹11 Cr | 2.54 | |
Mar2023 | ₹11 Cr | Positive | |
Mar2022 | ₹-0.68 Cr | Negative | |
Mar2021 | ₹3.63 Cr | -78.43 | |
Mar2020 | ₹17 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹410.9 Cr | 5.3% | -10.7% | -19.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹427,478.0 Cr | -1.3% | -4.8% | 45% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,822.0 Cr | 0.5% | 6.4% | 58.2% | Stock Analytics | |
CIPLA | ₹123,920.0 Cr | 2.1% | 3.8% | 24.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,322.0 Cr | -0.6% | -5.7% | 5.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,217.3 Cr | 0.1% | -3.6% | 48.2% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | 5.3% |
-10.7% |
-19.6% |
SENSEX | 0.9% |
-0.3% |
20.9% |
You may also like the below Video Courses